Skip to main content

Pfizer Biopharma revenue

  • PFE · NYSE
  • Pharmaceuticals
  • S&P 500
$28.89+0.21%Close 13 Nov 2026 · Market value $164.8B

Biopharma revenue at Pfizer came to $16.3B for the quarter to 27 Sep 2026, down 0.2% from a year earlier.

As Pfizer reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 3 Nov 2026.

By quarter

$14.2BDec 2023$14.6BMar 2024$13.0BJun 2024$17.4BSep 2024$17.4BDec 2024$13.4BMar 2025$14.3BJun 2025$16.3BSep 2025$17.1BDec 2025$14.2BMar 2026$14.7BJun 2026$16.3BSep 2026
Pfizer Biopharma revenue, every reported period
Period endingBiopharma revenueChange on a yearFiled
27 Sep 2026$16.3Bdown 0.2%3 Nov 2026
28 Jun 2026$14.7Bup 2.5%4 Aug 2026
29 Mar 2026$14.2Bup 5.4%5 May 2026
31 Dec 2025$17.1Bdown 1.6%26 Feb 2026
28 Sep 2025$16.3Bdown 6.2%4 Nov 2025
29 Jun 2025$14.3Bup 10.1%5 Aug 2025
30 Mar 2025$13.4Bdown 8.0%5 May 2025
31 Dec 2024$17.4Bup 22.7%27 Feb 2025
29 Sep 2024$17.4Bup 31.9%4 Nov 2024
30 Jun 2024$13.0Bup 2.4%5 Aug 2024
31 Mar 2024$14.6Bdown 19.6%8 May 2024
31 Dec 2023$14.2B—22 Feb 2024
1 Oct 2023$13.2B—4 Nov 2024
2 Jul 2023$12.7B—5 Aug 2024
2 Apr 2023$18.2B—8 May 2024

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Pfizer: Product revenue · Royalty revenue · Pfizer CentreOne revenue · Business Innovation Segment revenue · United States revenue · International Developed Markets revenue · International Emerging Markets revenue · financial statements

Every KPI and segment of PFE, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.